Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Pramod K. Kuchulakanti"'
Autor:
William W. Chu, Augusto D. Pichard, Pramod K. Kuchulakanti, Sundeep Mishra, Lowell F. Satler, Natalie Gevorkian, Zhenyi Xue, Ron Waksman, Leonardo C. Clavijo, William O. Suddath, Roswitha Wolfram, Rebecca Torguson, Kenneth M. Kent
Publikováno v:
The American Journal of Cardiology. 98:187-192
This study was performed to compare the safety and efficacy of sirolimus-eluting stents (SESs) and paclitaxel-eluting stents (PESs) on the outcomes of diabetic patients. Recent data with drug-eluting stents have shown improved clinical outcomes in di
Autor:
William W. Chu, Kenneth M. Kent, Ron Waksman, Lowell F. Satler, Rebecca Torguson, Augusto D. Pichard, Pramod K. Kuchulakanti, Leonardo C. Clavijo, William O. Suddath, Betty Wang
Publikováno v:
Cardiovascular Revascularization Medicine. 7:132-135
Background Bivalirudin is replacing heparin as the anticoagulant agent of choice for elective percutaneous coronary intervention (PCI). This study aimed to assess the safety and clinical outcomes of bivalirudin versus unfractionated heparin (UFH) in
Autor:
Afework GebreEyesus, Betty Wang, George Aggrey, Pramod K. Kuchulakanti, Lowell F. Satler, William W. Chu, Seung-Woon Rha, William O. Suddath, Rebecca Torguson, Leonardo C. Clavijo, Kenneth M. Kent, Ron Waksman, Zhenyi Xue, Augusto D. Pichard
Publikováno v:
The American Journal of Cardiology. 97:606-610
This retrospective analysis compared clinical outcomes of patients who underwent stenting withor =3 sirolimus-eluting stents (SESs) with those who received a single SES. SES (Cypher) implantation for single vessels is proved to be effective and durab
Autor:
Natalie Gevorkian, Zhenyi Xue, J. Fournadjieva, Sang Wook Kim, Pramod K. Kuchulakanti, William O. Suddath, Kenneth M. Kent, Leonardo C. Clavijo, Patrick Ohlmann, Seung-Woon Rha, Lowell F. Satler, Kimberly Smith, Ahn Bui, Augusto D. Pichard, Ron Waksman, Rebecca Torguson, William W. Chu
Publikováno v:
Circulation. 113:1108-1113
Background— Stent thrombosis (ST) is a serious complication of drug-eluting stent (DES) implantation regardless of the timing (acute, subacute, or late). The correlates of ST with DES are not yet completely elucidated. Methods and Results— From a
Autor:
Arnim Andreae, Eric Wittchow, Claus Harder, Roland Rohde, Pramod K. Kuchulakanti, Fermin O. Tio, Ron Waksman, Richard Baffour, Sonja Hartwig, Rajbabu Pakala, Bernd Heublein, Karl-Heinz Waldmann, Rufus Seabron, David Hellinga, Axel Haverich
Publikováno v:
Catheterization and Cardiovascular Interventions. 68:607-617
Objective: We aimed to determine the safety and efficacy of biobasorbable magnesium alloy stents in porcine coronary arteries. Bioabsorbable magnesium stents carry the potential to overcome the limitations posed by permanent metallic stents such as c
Autor:
Ellen Pinnow, William W. Chu, Lowell F. Satler, Edouard Cheneau, Kenneth M. Kent, Joseph Lindsay, Jana Alexieva-Fournadjiev, Seung-Woon Rha, Rebecca Torguson, Pramod K. Kuchulakanti, Ron Waksman, Augusto D. Pichard
Publikováno v:
The American Journal of Cardiology. 97:34-37
Saphenous vein graft (SVG) intervention is associated with a significantly increased rate of periprocedural complications and late clinical and angiographic restenosis. We examined the efficacy and safety of sirolimus-eluting stents (SESs; Cypher) co
Autor:
Jana Fournadjiev, Kenneth M. Kent, Daniel H. Steinberg, Lowell F. Satler, Ron Waksman, Rebecca Torguson, William O. Suddath, Pramod K. Kuchulakanti, Augusto D. Pichard, Leonardo C. Clavijo, William W. Chu
Publikováno v:
Catheterization and Cardiovascular Interventions. 68:873-878
This study examined the outcomes of patients who underwent sirolimus-eluting stent (SES) implantation for the treatment of heavily calcified coronary lesions (HCCL) with and without the use of rotational atherectomy (rotablator). We investigated 150
Autor:
Lowell F. Satler, Leonardo C. Clavijo, Kenneth M. Kent, Pramod K. Kuchulakanti, Ron Waksman, William W. Chu, Rebecca Torguson, William O. Suddath, Betty Wang, Augusto D. Pichard
Publikováno v:
Catheterization and Cardiovascular Interventions. 67:595-599
Background: Sirolimus-eluting stent (SES) implantation for the treatment of single coronary lesions is proven to be effective and durable. However, the safety and efficacy of overlapping SES for the treatment of long lesions have not been well establ
Autor:
Kenneth M. Kent, Rebecca Torguson, Augusto D. Pichard, Lowell F. Satler, Ron Waksman, Leonardo C. Clavijo, William O. Suddath, Pramod K. Kuchulakanti, William W. Chu, Betty Wang
Publikováno v:
Catheterization and Cardiovascular Interventions. 68:62-66
Objectives: The purpose of this study was to examine the clinical outcomes of patients who underwent stenting with ≥3 sirolimus-eluting stents (SES) when compared with those treated with ≥3 paclitaxel-eluting stents (PES). Background: Drug-elutin
Autor:
Leonardo C. Clavijo, Pramod K. Kuchulakanti, Augusto D. Pichard, William W. Chu, Kenneth M. Kent, Lowell F. Satler, Tina L. Pinto, Ron Waksman, Rebecca Torguson, William O. Suddath
Publikováno v:
Cardiovascular Revascularization Medicine. 7:7-11
Metabolic syndrome (MS), the combination of hypertension, obesity, dyslipidemia, and insulin resistance, is a precursor of diabetes mellitus (DM) and highly prevalent among patients with acute myocardial infarction (AMI). Diabetes mellitus is associa